<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://archinte.ama-assn.org">
<title>Archives of Internal Medicine current issue</title>
<link>http://archinte.ama-assn.org</link>
<description>Archives of Internal Medicine, a biweekly peer-reviewed, primary source journal, is widely recognized by physicians as the most relevant and practical journal in its specialty. Each issue offers a spectrum of articles relevant to everyday practice in general IM and subspecialty areas.</description>
<prism:coverDisplayDate>May 12 2008 12:00:00:000AM</prism:coverDisplayDate>
<prism:publicationName>Archives of Internal Medicine</prism:publicationName>
<prism:issn>0003-9926</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/906?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/908?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/909?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/912?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/920?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/928?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/935?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/936?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/943?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/950?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/959?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/969?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/979?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/987?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/995?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/996?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/1003?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/1010?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/1011?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/1011-a?rss=1" />
  <rdf:li rdf:resource="http://archinte.ama-assn.org/cgi/content/short/168/9/1012?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://archinte.ama-assn.org/icons/misc/titlereprint.gif" />
</channel>

<image rdf:about="http://archinte.ama-assn.org/icons/misc/titlereprint.gif">
<title>Archives of Internal Medicine</title>
<url>http://archinte.ama-assn.org/icons/misc/titlereprint.gif</url>
<link>http://archinte.ama-assn.org</link>
</image>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/906?rss=1">
<title><![CDATA[ABOUT THIS JOURNAL: About This Journal]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/906?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:title><![CDATA[ABOUT THIS JOURNAL: About This Journal]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>906</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>906</prism:startingPage>
<prism:section>About This Journal</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/908?rss=1">
<title><![CDATA[IN THIS ISSUE OF ARCHIVES OF INTERNAL MEDICINE: In This Issue of Archives of Internal Medicine]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/908?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:title><![CDATA[IN THIS ISSUE OF ARCHIVES OF INTERNAL MEDICINE: In This Issue of Archives of Internal Medicine]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>908</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>908</prism:startingPage>
<prism:section>In This Issue of Archives of Internal Medicine</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/909?rss=1">
<title><![CDATA[EDITORIAL: Air Pollution: What Is Bad for the Arteries Might Be Bad for the Veins]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/909?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Brook, R. D.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Venous Thromboembolism, Occupational and Environmental Medicine, Cardiovascular System, Cardiovascular Disease/ Myocardial Infarction]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.909</dc:identifier>
<dc:title><![CDATA[EDITORIAL: Air Pollution: What Is Bad for the Arteries Might Be Bad for the Veins]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>911</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>909</prism:startingPage>
<prism:section>Editorial</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/912?rss=1">
<title><![CDATA[SPECIAL ARTICLE: The Quality of Dying and Death]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/912?rss=1</link>
<description><![CDATA[
<p>During the past decade, research has examined definitions and conceptualizations of quality of dying and death in different populations. At the same time, there has been a call to clarify the distinctions between quality of dying and death and other end-of-life constructs. The purposes of this article are to (1) review research that examined definitions and conceptualizations of the quality of dying and death, (2) clarify the quality of dying and death construct and its distinction from quality of life and quality of care at the end of life, and (3) outline challenges that remain for health care professionals, researchers, and policy makers. Review of the literature revealed that the quality of dying and death construct is multidimensional, with 7 broad domains: physical experience, psychological experience, social experience, spiritual or existential experience, the nature of health care, life closure and death preparation, and the circumstances of death. The quality of dying and death is subjectively determined with numerous factors that influence its judgment, including culture, type and stage of disease, and social and professional role in the dying experience. Quality of dying and death is broader in scope than either quality of life at the end of life or quality of care at the end of life, although there is overlap among these constructs.</p>
]]></description>
<dc:creator><![CDATA[Hales, S., Zimmermann, C., Rodin, G.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Patient-Physician Relationship/ Care, End-of-life Care/ Palliative Medicine, Psychosocial Issues, Quality of Care, Quality of Care, Other, Quality of Life]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.912</dc:identifier>
<dc:title><![CDATA[SPECIAL ARTICLE: The Quality of Dying and Death]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>918</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>912</prism:startingPage>
<prism:section>Special Article</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/920?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: Exposure to Particulate Air Pollution and Risk of Deep Vein Thrombosis]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/920?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Particulate air pollution has been linked to heart disease and stroke, possibly resulting from enhanced coagulation and arterial thrombosis. Whether particulate air pollution exposure is related to venous thrombosis is unknown.</p>
<p><b>Methods&nbsp;</b> We examined the association of exposure to particulate matter of less than 10 &micro;m in aerodynamic diameter (PM<SUB>10</SUB>) with deep vein thrombosis (DVT) risk in 870 patients and 1210 controls from the Lombardy region in Italy, who were examined between 1995 and 2005. We estimated exposure to PM<SUB>10</SUB> in the year before DVT diagnosis (cases) or examination (controls) through area-specific mean levels obtained from ambient monitors.</p>
<p><b>Results&nbsp;</b> Higher mean PM<SUB>10</SUB> level in the year before the examination was associated with shortened prothrombin time (PT) in DVT cases (standardized regression coefficient [&beta;]&nbsp;=&nbsp;&ndash;0.12; 95% confidence interval [CI], &ndash;0.23 to 0.00) (<I>P</I>&nbsp;=&nbsp;.04) and controls (&beta;&nbsp;=&nbsp;&ndash;0.06; 95% CI, &ndash;0.11 to 0.00) (<I>P</I>&nbsp;=&nbsp;.04). Each increase of 10 &micro;g/m<sup>3</sup> in PM<SUB>10</SUB> was associated with a 70% increase in DVT risk (odds ratio [OR], 1.70; 95% CI, 1.30 to 2.23) (<I>P</I>&nbsp;&lt;&nbsp;.001) in models adjusting for clinical and environmental covariates. The exposure-response relationship was approximately linear over the observed PM<SUB>10</SUB> range. The association between PM<SUB>10</SUB> level and DVT risk was weaker in women (OR, 1.40; 95% CI, 1.02 to 1.92) (<I>P</I>&nbsp;=&nbsp;.02 for the interaction between PM<SUB>10</SUB> and sex), particularly in those using oral contraceptives or hormone therapy (OR, 0.97; 95% CI, 0.58 to 1.61) (<I>P</I>&nbsp;=&nbsp;.048 for the interaction between PM<SUB>10</SUB> level and hormone use).</p>
<p><b>Conclusions&nbsp;</b> Long-term exposure to particulate air pollution is associated with altered coagulation function and DVT risk. Other risk factors for DVT may modulate the effect of particulate air pollution.</p>
]]></description>
<dc:creator><![CDATA[Baccarelli, A., Martinelli, I., Zanobetti, A., Grillo, P., Hou, L.-F., Bertazzi, P. A., Mannucci, P. M., Schwartz, J.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Venous Thromboembolism, Occupational and Environmental Medicine, Cardiovascular System]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.920</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: Exposure to Particulate Air Pollution and Risk of Deep Vein Thrombosis]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>927</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>920</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/928?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: The Impact of Obesity on Cardiovascular Disease Risk Factors and Subclinical Vascular Disease: The Multi-Ethnic Study of Atherosclerosis]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/928?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> To assess the importance of the obesity epidemic on cardiovascular disease (CVD) risk, we determined the prevalence of obesity and the relationship of obesity to CVD risk factors and subclinical vascular disease.</p>
<p><b>Methods&nbsp;</b> The Multi-Ethnic Study of Atherosclerosis is an observational cohort study involving 6814 persons aged 45 to 84 years who were free of clinical CVD at baseline (2000-2002). The study assessed the association between body size and CVD risk factors, medication use, and subclinical vascular disease (coronary artery calcium, carotid artery intimal medial thickness, and left ventricular mass).</p>
<p><b>Results&nbsp;</b> A large proportion of white, African American, and Hispanic participants were overweight (60% to 85%) and obese (30% to 50%), while fewer Chinese American participants were overweight (33%) or obese (5%). Hypertension and diabetes were more prevalent in obese participants despite a much higher use of antihypertensive and/or antidiabetic medications. Obesity was associated with a greater risk of coronary artery calcium (17%), internal carotid artery intimal medial thickness greater than 80th percentile (32%), common carotid artery intimal medial thickness greater than 80th percentile (45%), and left ventricular mass greater than 80th percentile (2.7-fold greater) compared with normal body size. These associations persisted after adjustment for traditional CVD risk factors.</p>
<p><b>Conclusions&nbsp;</b> These data confirm the epidemic of obesity in most but not all racial and ethnic groups. The observed low prevalence of obesity in Chinese American participants indicates that high rates of obesity should not be considered inevitable. These findings may be viewed as indicators of potential future increases in vascular disease burden and health care costs associated with the obesity epidemic.</p>
]]></description>
<dc:creator><![CDATA[Burke, G. L., Bertoni, A. G., Shea, S., Tracy, R., Watson, K. E., Blumenthal, R. S., Chung, H., Carnethon, M. R.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Public Health, Obesity, Cardiovascular System, Public Health, Other, Cardiovascular Disease/ Myocardial Infarction]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.928</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: The Impact of Obesity on Cardiovascular Disease Risk Factors and Subclinical Vascular Disease: The Multi-Ethnic Study of Atherosclerosis]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>935</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>928</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/935?rss=1">
<title><![CDATA[CORRECTION: Error in Misspelled Author Surname in: Estrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/935?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Oncology, Breast Cancer, Radiologic Imaging, Women's Health, Women's Health, Other, Diagnosis, Mammography, Drug Therapy, Adverse Effects]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.935</dc:identifier>
<dc:title><![CDATA[CORRECTION: Error in Misspelled Author Surname in: Estrogen Plus Progestin and Breast Cancer Detection by Means of Mammography and Breast Biopsy]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>935</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>935</prism:startingPage>
<prism:section>Correction</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/936?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: Tuberculosis in South Asians Living in the United States, 1993-2004]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/936?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Patients with tuberculosis (TB) in the United States are often described in 2 broad categories, US-born and foreign-born, which may mask differences among different immigrant groups. We determined characteristics of patients born in South Asia and diagnosed as having TB in the United States.</p>
<p><b>Methods&nbsp;</b> All 224&nbsp;101 TB cases reported to the US National Tuberculosis Surveillance System from the 50 states and the District of Columbia from 1993 to 2004 were included. We used descriptive analysis and logistic regression to explore differences among patients born in South Asia, other foreign-born, and US-born TB patients.</p>
<p><b>Results&nbsp;</b> Half of the South Asian TB patients (50.5%) in our study were in the 25- to 44-year-old age group, compared with 40.1% of other foreign-born TB patients and 31.8% of US-born TB patients. Compared with other foreign-born TB patients, South Asians were more likely to have extrapulmonary disease (odds ratio [OR],&nbsp;1.7), more likely to be uninfected with human immunodeficiency virus (HIV) (OR,&nbsp;5.8) but also more likely not to be offered HIV testing (OR,&nbsp;9.4) or not to accept an HIV test if offered (OR,&nbsp;11.8), and more likely not to be homeless (OR,&nbsp;2.9) or not to use drugs or excess alcohol (OR,&nbsp;2.7).</p>
<p><b>Conclusions&nbsp;</b> South Asian TB patients in the United States are younger and more commonly develop extrapulmonary TB than other foreign-born patients. New TB control strategies that target younger patients and that encourage HIV testing and inform physicians about high extrapulmonary TB in the absence of common risk factors in South Asians are needed.</p>
]]></description>
<dc:creator><![CDATA[Asghar, R. J., Pratt, R. H., Kammerer, J. S., Navin, T. R.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Bacterial Infections, HIV/AIDS, Tuberculosis/ Other Mycobacterium, Public Health, Public Health, Other, Infectious Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.936</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: Tuberculosis in South Asians Living in the United States, 1993-2004]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>942</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>936</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/943?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: The Relationship Between Fatigue and Cardiac Functioning]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/943?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Although characteristics such as heart rate (HR) and blood pressure (BP) are commonly reported in studies of the relationship between fatigue and cardiac functioning, few reports examine how cardiac function parameters such as cardiac output (CO) and stroke volume (SV) relate to fatigue. This study examined the relationship between self-reported fatigue and hemodynamic functioning at rest and in response to a public speaking stressor in healthy individuals.</p>
<p><b>Methods&nbsp;</b> A total of 142 individuals participated in this study. Subjects were placed in low-, moderate-, or high-fatigue groups based on their Profile of Moods State fatigue scale. Heart rate, SV, and CO were determined using impedance cardiography at rest and during a speaking stressor. Stroke volume and CO values were converted to stroke index (SI) and cardiac index (CI) by adjusting for body surface area. Data were analyzed with hierarchical regression analysis and a 3 (group)&nbsp;<FONT FACE="arial,helvetica">x</FONT>&nbsp;3 (stress period) mixed model analysis of variance.</p>
<p><b>Results&nbsp;</b> At rest, fatigue was not associated with BP or HR but was significantly associated with decreased CI (<I>P</I>&nbsp;&lt;&nbsp;.001; 95% confidence interval, &ndash;0.046 to &ndash;0.014) and stroke index (SI) (<I>P</I>&nbsp;=&nbsp;.002; 95% confidence interval &ndash;0.664 to &ndash;0.151), even after controlling for demographic variables and depressive symptoms. Heart rate and BP increased, as expected, from baseline to preparation to speaking stressor (<I>F</I>  <SUB>1,124</SUB>&nbsp;=&nbsp;118.6 and <I>F</I>  <SUB>1,122</SUB>&nbsp;=&nbsp;46.450, respectively) (<I>P</I>&nbsp;&lt;&nbsp;.001 for both). More interestingly, there were effects on SI and CI of fatigue (<I>P</I>&lt;.03 for both) and stress (<I>P</I>&lt;.03 for both); high-fatigue individuals had lower SI and CI levels than moderate- and low-fatigue individuals both at rest and in response to the stressor.</p>
<p><b>Conclusion&nbsp;</b> This study demonstrates that fatigue complaints may have hemodynamic correlates even in ostensibly healthy individuals.</p>
]]></description>
<dc:creator><![CDATA[Nelesen, R., Dar, Y., Thomas, K., Dimsdale, J. E.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Neurology, Cardiovascular System, Other, Neuromuscular diseases, Psychiatry, Stress, Cardiovascular System, Rheumatology, Musculoskeletal Syndromes (Chronic Fatigue, Gulf War), Cardiovascular Disease/ Myocardial Infarction]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.943</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: The Relationship Between Fatigue and Cardiac Functioning]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>949</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>943</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/950?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: Use of Recommended Ambulatory Care Services: Is the Veterans Affairs Quality Gap Narrowing?]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/950?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Veterans Affairs medical centers (VAMCs) provide better preventive and chronic disease care when compared with other health care organizations, although recent health care quality improvement initiatives outside the VAMC sector may have narrowed quality differences.</p>
<p><b>Methods&nbsp;</b> Using the nationally representative 2000 and 2004 surveys of the Behavior Risk Factor Surveillance System, which included 152&nbsp;310 community-dwelling insured adults in 2000 and 251&nbsp;570 in 2004, we compared self-reported use of 17 recommended ambulatory care services for cancer prevention, cardiovascular risk reduction, diabetes mellitus management, and infectious disease prevention among insured adults receiving and not receiving care at VAMCs.</p>
<p><b>Results&nbsp;</b> A total of 2852 insured adults (1.9%) received care at VAMCs in 2000 and 7155 (2.4%) received care at VAMCs in 2004. Use of 9 of the 17 services was greater in 2004 when compared with 2000 (<I>P</I>&nbsp;&le;&nbsp;.05). In 2000, receiving VAMC care was associated with greater use of 6 of the 17 services; in 2004, receiving VAMC care was associated with greater use of 12 of the 17 services (<I>P</I>&nbsp;&le;&nbsp;.05). In 2004, greater use among these 12 services ranged from 10% greater use of cholesterol screening to 40% greater use of colorectal cancer screening. For 13 of the 17 services, the likelihood of service use among adults receiving VAMC care when compared with adults not receiving VAMC care was not significantly different in 2004 than in 2000. However, this likelihood was significantly greater (for VAMC vs non-VAMC use) in 2004 than in 2000 for breast cancer screening (relative risk [RR], 1.21 [95% confidence interval {CI}, 1.15-1.25] vs 0.80 [95% CI, 0.58-0.98]; <I>P</I>&nbsp;&lt;&nbsp;.001), dilated eye examination among adults with diabetes (RR, 1.12 [95% CI, 1.07-1.15] vs 1.01 [95% CI, 0.88-1.09]; <I>P</I>&nbsp;=&nbsp;.04), and influenza (RR, 1.30 [95% CI, 1.24-1.36] vs 1.06 [95% CI, 0.89-1.21]; <I>P</I>&nbsp;=&nbsp;.006) and pneumococcal (RR, 1.27 [95% CI, 1.23-1.31] vs 1.04 [95% CI, 0.86-1.21]; <I>P</I>&nbsp;=&nbsp;.005) vaccinations.</p>
<p><b>Conclusion&nbsp;</b> Despite increasing emphasis on quality of care and improved performance throughout the US health care system, adults receiving VAMC care remain more likely to receive recommended ambulatory care.</p>
]]></description>
<dc:creator><![CDATA[Ross, J. S., Keyhani, S., Keenan, P. S., Bernheim, S. M., Penrod, J. D., Boockvar, K. S., Federman, A. D., Krumholz, H. M., Siu, A. L.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Oncology, Oncology, Other, Cardiovascular System, Quality of Care, Quality of Care, Other, Cardiovascular Disease/ Myocardial Infarction, Endocrine Diseases, Diabetes Mellitus]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.950</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: Use of Recommended Ambulatory Care Services: Is the Veterans Affairs Quality Gap Narrowing?]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>958</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>950</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/959?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: Factors Associated With Longer Time From Symptom Onset to Hospital Presentation for Patients With ST-Elevation Myocardial Infarction]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/959?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Previous studies have demonstrated the effects of single factors, such as age, sex, and race, with longer delays from symptom onset to hospital presentation in patients with ST-elevation myocardial infarction.</p>
<p><b>Methods&nbsp;</b> We studied risk factors individually and in combination to determine the cumulative effect on delay times in 482&nbsp;327 patients with ST-elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction between January 1, 1995, and December 31, 2004. We analyzed patient subgroups with the following risk factors in combination: younger than70 years vs 70 years and older, race/ethnicity, men vs women, and nondiabetic vs diabetic.</p>
<p><b>Results&nbsp;</b> The geometric mean for delay time was 114 minutes, with a decreasing trend from 123 minutes in 1995 to 113 minutes in 2004 (<I>P</I>&nbsp;&lt;&nbsp;.001). Nearly half of the patients (45.5%) presented more than 2 hours and 8.7% presented more than 12 hours after the onset of symptoms. Compared with the reference group (those &lt;&nbsp;70 years, men, white, and did not have diabetes mellitus [DM]), subgroups with longer delay times (<I>P</I>&nbsp;&lt;&nbsp;.01 for all) included those younger than 70 years, men, black, and had DM (+43 minutes); those younger than 70 years, women, black, and had DM (+55 minutes); those 70 years and older, men, black, and had DM (+60 minutes); and those 70 years and older, women, black, and had DM (+63 minutes).</p>
<p><b>Conclusions&nbsp;</b> Patient subgroups with a combination of factors (older age, women, Hispanic or black race, and DM) have particularly long delay times that may be 60 minutes longer than subgroups without those characteristics. Improving patient responsiveness in these subgroups represents an important opportunity to improve quality of care and minimize disparities in care.</p>
]]></description>
<dc:creator><![CDATA[Ting, H. H., Bradley, E. H., Wang, Y., Lichtman, J. H., Nallamothu, B. K., Sullivan, M. D., Gersh, B. J., Roger, V. L., Curtis, J. P., Krumholz, H. M.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Aging/ Geriatrics, Medical Practice, Medical Practice, Other, Cardiovascular System, Women's Health, Women's Health, Other, Cardiovascular Disease/ Myocardial Infarction, Emergency Medicine, Endocrine Diseases, Diabetes Mellitus]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.959</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: Factors Associated With Longer Time From Symptom Onset to Hospital Presentation for Patients With ST-Elevation Myocardial Infarction]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>968</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>959</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/969?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/969?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> The utility of metabolic syndrome (MetS) for predicting mortality among older adults, the highest-risk population, is not well established. In addition, few studies have compared the predictive utility of MetS to that of its individual risk factors.</p>
<p><b>Methods&nbsp;</b> We evaluated relationships of MetS (as defined by the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults [Adult Treatment Panel III (ATPIII)], International Diabetes Foundation [IDF], and World Health Organization [WHO]) and individual MetS criteria with mortality between 1989 and 2004 among 4258 US adults 65 years or older and free of prevalent cardiovascular disease (CVD) in the Cardiovascular Health Study, a multicenter, population-based, prospective cohort. Total, CVD, and non-CVD mortality were evaluated. Cox proportional hazards models were used to estimate the mortality hazard ratio (relative risk [RR]) predicted by MetS.</p>
<p><b>Results&nbsp;</b> At baseline (mean age, 73 years), 31% of men and 38% of women had MetS (ATPIII). During 15 years of follow-up, 2116 deaths occurred. After multivariable adjustment, compared with persons without MetS, those with MetS had a 22% higher mortality (RR, 1.22; 95% confidence interval [CI], 1.11-1.34). Higher risk with MetS was confined to persons having elevated fasting glucose level (EFG) (defined as &ge;&nbsp;110 mg/dL [&ge;&nbsp;6.1 mmol/L] or treated diabetes mellitus) (RR, 1.41; 95% CI, 1.27-1.57) or hypertension (RR, 1.26; 95% CI, 1.15-1.39) as one of the criteria; persons having MetS without EFG (RR, 0.97; 95% CI, 0.85-1.11) or MetS without hypertension (RR, 0.92; 95% CI, 0.71-1.19) did not have higher risk. Evaluating MetS criteria individually, we found that only hypertension and EFG predicted higher mortality; persons having both hypertension and EFG had 82% higher mortality (RR, 1.82; 95% CI, 1.58-109). Substantially higher proportions of deaths were attributable to EFG and hypertension (population attributable risk fraction [PAR%], 22.2%) than to MetS (PAR%, 6.3%). Results were similar when we used WHO or IDF criteria, when we evaluated different cut points of each individual criterion, and when we evaluated CVD mortality.</p>
<p><b>Conclusion&nbsp;</b> These findings suggest limited utility of MetS for predicting total or CVD mortality in older adults compared with assessment of fasting glucose and blood pressure alone.</p>
]]></description>
<dc:creator><![CDATA[Mozaffarian, D., Kamineni, A., Prineas, R. J., Siscovick, D. S.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Aging/ Geriatrics, Nutritional and Metabolic Disorders, Lipids and Lipid Disorders, Metabolic Diseases, Public Health, Obesity, Cardiovascular System, Cardiovascular Disease/ Myocardial Infarction]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.969</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>978</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>969</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/979?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: Counseling for Home-Based Walking and Strength Exercise in Older Primary Care Patients]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/979?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> We evaluated the effects of counseling linked with primary care visits on walking and "strength exercise" (the combination of strength-building and flexibility exercise) in aging veterans.</p>
<p><b>Methods&nbsp;</b> Male veterans aged 60 to 85 years (N&nbsp;=&nbsp;224) with physical function limitations were randomized to either counseling for home-based walking and strength exercise (EXC) or discussion of their choice of health education topics (EDUC) with a nurse at baseline, 1 month, and 5 months. The EXC participants recorded exercise on monthly calendars and received brief follow-up calls from the nurse; all participants received bimonthly newsletters throughout the 10-month trial.</p>
<p><b>Results&nbsp;</b> Retention was 83% in the EXC group and 97% in the EDUC group (<I>P</I>&nbsp;&lt;&nbsp;.001). With analyses using the last observation carried forward approach, the EXC participants reported more walking time per week at 5 and 10 months (64.5 and 60.6 min/wk, respectively, for the EXC group vs 50.5 and 45.7 min/wk, respectively, for the EDUC group; 2.4 d/wk and 2.3 d/wk, respectively, for the EXC group vs 1.8 and 1.7 d/wk, respectively, for the EDUC group) (<I>P</I>&nbsp;&lt;&nbsp;.001). The EXC participants also reported more strength exercise at 5 and 10 months (44.6 and 41.2 min/wk, respectively, for the EXC group vs 19.8 and 14.7 min/wk, respectively, for the EDUC group; 2.1 and 2.0 d/wk, respectively, for the EXC group vs 0.8 and 0.8 d/wk, respectively, for the EDUC group) (<I>P</I>&nbsp;&lt;&nbsp;.001). The EXC participants reported more frequent moderate- or higher-intensity physical activity (7.1 vs 5.1 sessions/wk) (<I>P</I>&nbsp;&lt;&nbsp;.001). Findings from accelerometer-measured physical activity indicated more EXC than EDUC participants (64% vs 46%), who averaged 30 min/d or more of moderate- or higher-intensity physical activity (<I>P</I>&nbsp;=&nbsp;.03). Participants engaging in strength exercise improved physical performance and reported positive changes in quality of life.</p>
<p><b>Conclusion&nbsp;</b> Relatively brief counseling linked with primary care visits can increase home-based walking and strength exercise in aging male veterans.</p>
<p><b>Trial Registration&nbsp;</b> clinicaltrials.gov Identifier: <inter-ref locator-type="url" locator="http://clinicaltrials.gov/show/NCT00013195">NCT00013195</inter-ref>  </p>
]]></description>
<dc:creator><![CDATA[Dubbert, P. M., Morey, M. C., Kirchner, K. A., Meydrech, E. F., Grothe, K.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Aging/ Geriatrics, Patient-Physician Relationship/ Care, Patient Education/ Health Literacy, Primary Care/ Family Medicine, Public Health, Exercise]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.979</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: Counseling for Home-Based Walking and Strength Exercise in Older Primary Care Patients]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>986</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>979</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/987?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: Long-term Prognosis of Acute Kidney Injury After Acute Myocardial Infarction]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/987?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Acute kidney injury (AKI) is a common complication during hospitalization and is an accepted risk factor for in-hospital mortality. However, the association of severity of AKI with the long-term risk of death is not well defined.</p>
<p><b>Methods&nbsp;</b> To examine the independent effect of the severity of AKI on long-term risk of death following acute myocardial infarction (AMI), we performed an observational study of 147007 elderly Medicare patients admitted for AMI from January 1994 through February 1996 as a part of the Cooperative Cardiovascular Project. We evaluated the association between AKI and all-cause mortality. We defined AKI as absolute changes in serum creatinine level, categorized as none (creatinine level increase, &le;0.2 mg/dL), mild (0.3-0.4 mg/dL increase), moderate (0.5-0.9 mg/dL increase), and severe (&ge;1.0 mg/dL increase).</p>
<p><b>Results&nbsp;</b> Overall, 19.4% of the patients had AKI, including 7.1% with mild AKI, 7.1% with moderate AKI, and 5.2% with severe AKI. Less than 10% of patients who had severe AKI were alive at 10 years compared with 12.2%, 21.1%, and 31.7% patients with moderate, mild, and no AKI, respectively. The adjusted hazard ratio for death for in-hospital survivors at 10 years was 1.15 (95% confidence interval [CI], 1.12-1.18) for mild AKI, 1.23 (95% CI, 1.20-1.26) for moderate AKI, and 1.33 (95% CI, 1.28-1.38) for severe AKI. Similar results were obtained in several secondary analyses that included inpatient mortality, excluded mortality in the first 3 years, and stratified by some specified high-risk groups. Moderate or severe AKI were comparable in strength with other known correlates of cardiovascular mortality.</p>
<p><b>Conclusions&nbsp;</b> Acute kidney injury has an independent and graded association with long-term mortality. These results should stimulate additional mechanistic and interventional studies and plans for follow-up of patients with AKI after discharge.</p>
]]></description>
<dc:creator><![CDATA[Parikh, C. R., Coca, S. G., Wang, Y., Masoudi, F. A., Krumholz, H. M.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Cardiovascular System, Renal Diseases, Renal Diseases, Other, Prognosis/ Outcomes, Cardiovascular Disease/ Myocardial Infarction]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.987</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: Long-term Prognosis of Acute Kidney Injury After Acute Myocardial Infarction]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>995</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>987</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/995?rss=1">
<title><![CDATA[CORRECTION: Errors in Figure in: Using Video Images of Dementia in Advance Care Planning]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/995?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:identifier>info:doi/10.1001/archinte.168.9.995</dc:identifier>
<dc:title><![CDATA[CORRECTION: Errors in Figure in: Using Video Images of Dementia in Advance Care Planning]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>995</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>995</prism:startingPage>
<prism:section>Correction</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/996?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: Racial Differences in Diurnal Blood Pressure and Heart Rate Patterns: Results From the Dietary Approaches to Stop Hypertension (DASH) Trial]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/996?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Several studies have suggested that blacks, on average, have a blunted decline in nocturnal blood pressure (BP) as compared with nonblacks. It is unknown whether differences in traditional determinants of BP, specifically diet and obesity, account for observed differences in diurnal patterns.</p>
<p><b>Methods&nbsp;</b> We conducted an analysis of the Dietary Approaches to Stop Hypertension (DASH) trial that enrolled adults with prehypertension or stage 1 hypertension. At the end of a 3-week run-in period, ambulatory BP monitoring data were obtained on 333 participants, all of whom ate the same diet. Mean ambulatory daytime (6 <scp>am</scp>&ndash;11 <scp>pm</scp>) and nighttime (11 <scp>pm</scp>&ndash;6 <scp>am</scp>) systolic BP, diastolic BP, and heart rate (HR) were measured. Dipping was defined as a nighttime drop of less than 10% from mean daytime values.</p>
<p><b>Results&nbsp;</b> Office BP was similar in blacks and nonblacks, as were 24-hour and daytime BP and HR. However, blacks demonstrated a statistically significant, blunted nocturnal decline in BP and HR. Blacks were significantly more likely than nonblacks to have systolic nondipping (44.9% vs 26.7%, <I>P</I>&nbsp;=&nbsp;.001), diastolic nondipping (20.9% vs 11.6%, <I>P</I>&nbsp;=&nbsp;.03), and HR nondipping (40.9% vs 19.9%, <I>P</I>&nbsp;&lt;&nbsp;.001). These differences persisted after adjustment for site, sex, age, body mass index, alcohol intake, physical activity, office BP (or HR), education, and income.</p>
<p><b>Conclusion&nbsp;</b> Blacks with similar office BP, and who consumed the same diet as nonblacks, had a blunted nocturnal decline in systolic BP, diastolic BP, and HR, even after factors that influence BP were controlled for.</p>
]]></description>
<dc:creator><![CDATA[Jehn, M. L., Brotman, D. J., Appel, L. J.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Cardiovascular System, Other, Cardiovascular System, Hypertension]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.996</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: Racial Differences in Diurnal Blood Pressure and Heart Rate Patterns: Results From the Dietary Approaches to Stop Hypertension (DASH) Trial]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>1002</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>996</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/1003?rss=1">
<title><![CDATA[ORIGINAL INVESTIGATION: Association Between Colorectal Cancer and Urologic Cancers]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/1003?rss=1</link>
<description><![CDATA[
<p><b>Background&nbsp;</b> Different types of urologic cancers have been associated with colorectal cancer (CRC) in hereditary nonpolyposis CRC, but it is still unknown whether there is an association between urologic cancer and CRC in the general population. We sought to quantify the risk for CRC after urologic cancer and the risk for urologic cancer after CRC in patients without known genetic syndromes.</p>
<p><b>Methods&nbsp;</b> We performed a retrospective cohort analysis of the Surveillance, Epidemiology, and End Results program database from 1973 to 2000. Standard incidence ratios (SIRs) of observed to expected cases of invasive CRC were calculated for each urologic cancer site based on age, sex, ethnicity, and calendar year of diagnosis. Similar analysis was performed to determine the SIRs of urologic cancers in patients with previous CRC.</p>
<p><b>Results&nbsp;</b> Overall, the risk for CRC was increased among patients with previous ureteral cancer (SIR, 1.80; 95% confidence interval [CI], 1.46-2.20) and renal pelvis cancer (SIR, 1.44; 95% CI, 1.20-1.72). This risk was greatest among patients who received the diagnosis of renal pelvis or ureteral cancer before the age of 60 years. There was a minimal increased risk for subsequent CRC in patients with bladder or renal parenchymal cancer. Overall, the risk for urologic cancer was increased after a diagnosis of CRC (SIR, 1.24; 95% CI, 1.20-1.28), with the highest risk for subsequent renal pelvis and ureteral cancers in patients with a CRC diagnosis before the ages of 50 to 60 years or multiple primary CRCs.</p>
<p><b>Conclusions&nbsp;</b> Previous renal pelvis and ureteral cancers, particularly when diagnosed at an early age, increase the risk for subsequent CRC. Likewise, a history of CRC, especially in cases with multiple primary tumors, is associated with an increased risk of renal pelvis and ureteral cancers. These findings support a possible common pathogenetic mechanism between CRC and urologic cancers and may have implications for screening guidelines.</p>
]]></description>
<dc:creator><![CDATA[Calderwood, A. H., Huo, D., Rubin, D. T.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Oncology, Colon Cancer, Urinary Tract Disorders, Gastroenterology, Gastrointestinal Diseases]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.1003</dc:identifier>
<dc:title><![CDATA[ORIGINAL INVESTIGATION: Association Between Colorectal Cancer and Urologic Cancers]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>1009</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>1003</prism:startingPage>
<prism:section>Original Investigation</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/1010?rss=1">
<title><![CDATA[EDITOR'S CORRESPONDENCE: Hospitalist Care and Length of Stay in Patients With Hip Fracture: A Systematic Review]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/1010?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Nigwekar, S. U., Rajda, J., Navaneethan, S. D.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Medical Practice, Medical Practice, Other, Quality of Care, Evidence-Based Medicine, Quality of Care, Other, Surgery, Surgical Interventions, Orthopedic Surgery]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.1010</dc:identifier>
<dc:title><![CDATA[EDITOR'S CORRESPONDENCE: Hospitalist Care and Length of Stay in Patients With Hip Fracture: A Systematic Review]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>1011</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>1010</prism:startingPage>
<prism:section>Editor's Correspondence</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/1011?rss=1">
<title><![CDATA[EDITOR'S CORRESPONDENCE: German Acupuncture Trials for Chronic Low Back Pain]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/1011?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Wand, B. M., O'Connell, N.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Complementary and Alternative Medicine, Pain, Statistics and Research Methods]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.1011-a</dc:identifier>
<dc:title><![CDATA[EDITOR'S CORRESPONDENCE: German Acupuncture Trials for Chronic Low Back Pain]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>1011</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>1011</prism:startingPage>
<prism:section>Editor's Correspondence</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/1011-a?rss=1">
<title><![CDATA[EDITOR'S CORRESPONDENCE: Sham Acupuncture Is Not a Placebo]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/1011-a?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Li, S. M., Costi, J. M., Teixeira, J. E. M.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Complementary and Alternative Medicine, Pain, Statistics and Research Methods]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.1011-b</dc:identifier>
<dc:title><![CDATA[EDITOR'S CORRESPONDENCE: Sham Acupuncture Is Not a Placebo]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>1011</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>1011</prism:startingPage>
<prism:section>Editor's Correspondence</prism:section>
</item>

<item rdf:about="http://archinte.ama-assn.org/cgi/content/short/168/9/1012?rss=1">
<title><![CDATA[EDITOR'S CORRESPONDENCE: Sham Acupuncture Is Not a Placebo--Reply]]></title>
<link>http://archinte.ama-assn.org/cgi/content/short/168/9/1012?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Endres, H. G., Molsberger, A., Haake, M.]]></dc:creator>
<dc:date>2008-05-12</dc:date>
<dc:subject><![CDATA[Complementary and Alternative Medicine, Pain, Statistics and Research Methods]]></dc:subject>
<dc:identifier>info:doi/10.1001/archinte.168.9.1012</dc:identifier>
<dc:title><![CDATA[EDITOR'S CORRESPONDENCE: Sham Acupuncture Is Not a Placebo--Reply]]></dc:title>
<dc:publisher>American Medical Association</dc:publisher>
<prism:number>9</prism:number>
<prism:volume>168</prism:volume>
<prism:endingPage>1012</prism:endingPage>
<prism:publicationDate>2008-05-12</prism:publicationDate>
<prism:startingPage>1012</prism:startingPage>
<prism:section>Editor's Correspondence</prism:section>
</item>

</rdf:RDF>